Search

Filters
Clear All
  • 1
  • 16

Phase

  • 1
  • 1
  • 15
  • 15
  • 8
  • 16
  • 1

Found 17 Nephropathy trials

A listing of Nephropathy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Stronger Hearts, Healthier Lives: Join Our Study
N
Navin Kaushal
18 years - 100 years
All genders
Why is this study being done?Cardiokidney Metabolic Syndrome or CKM is a new syndrome recognized by the American Heart Association and occurs when an individual has a combination of conditions which includes being overweight, in addition to having metabolic risk factors (hypertriglyceridemia [≥135 mg/dL], hypertension, metabolic syndrome, diabetes), or chronic …
Check Eligibility
Online study
 Adults With or Without Chronic Kidney Disease Needed for CBD Study
M
Michael Eadon, MD
18 years - 75 years
Accepts healthy volunteer
All genders
Phase 1
Have you ever wondered about the safety of medicinal CBD?  Join our study!  What is this study about?The goal of this study is to assess the safety of CBD with tacrolimus, an agent taken by transplant patients to prevent organ rejection. This study seeks to understand the interaction between CBD and …
K
Kenneth Lim
18 years - 100 years
All genders
The aim of this study is to compare the effects of home dialysis, peritoneal dialysis, and conventional three times a week dialysis on cardiovascular functional capacity (the parts of your body including the heart, blood vessels, and lungs that move air around your body and helps remove waste products). All …
J
Jean Molleston, MD
3 years - 65 years
All genders
Use Fibroscan to determine thevalence of CHF in an ADPKD population and the incidence over a four-yeard in these patients. Use Fibroscan to determine thevalence of congenital hepatic fibrosis in an ARPKD population Use fibroscan to determine thevalence of fibrotic liver disease in patients with other cystic kidneydiseases such as …
K
Kenneth Lim
18 years - 100 years
All genders
Interventional
What is the purpose of this study?The purpose of the study is to assess the therapeutic benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors in improving physical function in End Stage Renal disease (ESRD) patients.  The study is using the drug Empagliflozin, a FDA approved drug for patients with advanced CKD. …
D
David A. Peterson, MD
18 years or above
Female
Phase 3
Interventional
The goal of this clinical trial is to compare the number of catheter-free days (CFD) and thed severity of any dialysis access-related infections between the HAV and AVF groupsver 12 months in patients with end-stage renal disease (ESRD) needing hemodialysis (HD). Participants will be stratified by location of the vascular …
 Medication Adherence Given Individual SystemCHANGE(TM) in Advancing Nephropathy (MAGICIAN) Pilot Study
R
Rebecca Ellis
18 years - 100 years
All genders
Interventional
The purpose of this study is to try new ways to improve the way that people with chronic kidney disease manage their health.
J
John Christenson, MD
18 years - 100 years
All genders
Interventional
What is the purpose of this study?The purpose of this study is to gather information on cardiovascular changes in conventional hemodialysis, and peritoneal dialysis patients. Research indicates that cardiovascular disease remains the leading cause of death among patients with chronic kidney disease (CKD) and those on dialysis.THIS STUDY IS ENROLLING …
K
Kenneth Lim
18 years - 100 years
All genders
Interventional
What is the purpose of this study?The purpose of this study is to gather information on cardiovascular changes in hemodialysis patients, both home-hemo and conventional hemo-dialysis. Research indicates that cardiovascular disease remains the leading cause of death among patients with chronic kidney disease (CKD) and those on dialysis.THIS STUDY IS …
M
Marciana Laster
6 months - 17 years
All genders
What is the purpose of this study?The primary goals of this study are to determine the risk factors for decline in kidney function and to define how a progressive decline in kidney function impacts neurocognitive function and behavior; the risk factors for cardiovascular disease; and growth failure and its associated …
1 - 10 of 17